App-Quantinova.ai

ELEVATED TROPONINS PREDICT LONG-TERM CARDIOVASCULAR OUTCOMES IN ACUTE CEREBROVASCULAR ACCIDENT PATIENTS WITHOUT ACUTE CORONARY SYNDROME

Farhan Raza - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SILENT ATRIAL FIBRILLATION BURDEN IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Ankur Kalra - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

ASSOCIATION OF ARRHYTHMIAS WITH OUTCOMES IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: AN ANALYSIS OF THE NATIONWIDE INPATIENT SAMPLE 2003-2011

Prakash Harikrishnan - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

BURDEN OF ARRHYTHMIAS IN PATIENTS WITH ALCOHOLIC CARDIOMYOPATHY: FINDINGS FROM THE NATIONWIDE INPATIENT SAMPLE 2003-2011

Prakash Harikrishnan - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SAFETY AND EFFICACY OF SUBCUTANEOUS IMPLANTABLE-CARDIOVERTER DEFIBRILLATOR IMPLANTATION: A SINGLE CENTER EXPERIENCE

Eduard Koman - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

OUTCOMES OF TEMPORARY ACTIVE-FIXATION LEAD IMPLANTATION AFTER TRANSVENOUS LEAD EXTRACTION IN PACEMAKER DEPENDENT PATIENTS

Eduard Koman - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

PERMANENT DEVICE IMPLANTATION USING THE TRANSFEMORAL ROUTE

Srinivas Rajsheker - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

PROGNOSIS IN STRESS CARDIOMYOPATHY IS PREDICTED BY QTC INTERVAL AT PRESENTATION

Mukesh Gopalakrishnan - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Catecholamine

ASSESSMENT OF EUROPEAN SOCIETY OF CARDIOLOGY SUDDEN CARDIAC DEATH RISK MODEL FOR HYPERTROPHIC CARDIOMYOPATHY

Barry J. Maron - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ETIOLOGIES OF SUDDEN CARDIAC DEATH ASSOCIATED WITH PHYSICAL EXERTION IN THE UNITED STATES MILITARY

Samuel O. Jones - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

CHANGES IN FOLLOW-UP LEFT VENTRICULAR EJECTION FRACTION ASSOCIATED WITH OUTCOMES IN PRIMARY PREVENTION ICD RECIPIENTS

Yiyi Zhang - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

PROCEDURAL BENEFIT OF SUBSTRATE BASE ABLATION VERSUS CONVENTIONAL MAPPING AND ABLATION OF CLINICAL STABLE VENTRICULAR TACHYCARDIA: RESULTS FROM THE VISTA RANDOMIZED TRIAL

Luigi Di Biase - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Vista

AMIODARONE DESENSITIZATION BY A NOVEL PROTOCOL IN A PATIENT WITH ADVANCED BIVENTRICULAR HEART FAILURE AND RECURRENT VENTRICULAR TACHYCARDIA

Miriam Freundt - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Methylprednisolone

THE PROFILE OF SURVIVORS OF COMMUNITY PEDIATRIC SUDDEN CARDIAC ARREST

Barry A. Love - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ECHOCARDIOGRAPHIC PREDICTORS OF LONG TERM OUTCOMES IN PATIENTS UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY: WHAT IS THE OPTIMAL METRIC?

John Rickard - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

IMPAIRED BASELINE GLOBAL CIRCUMFERENTIAL STRAIN IS A MARKER FOR VENTRICULAR ARRHYTHMIAS AFTER RESYNCHRONIZATION THERAPY IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY

Antonia Delgado-Montero - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE POST-IMPLANTATION ELECTROCARDIOGRAM PREDICTS CLINICAL RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY

Edward Coverstone - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

FIXED AND DYNAMIC LEFT VENTRICULAR OUTFLOW OBSTRUCTIONS IN TANDEM: NOT A ROUTINE PREOPERATIVE EVALUATION

Selma Mohammed - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Phenylephrine

LOFFLERs ENDOCARDITIS PRESENTING AS CARDIOGENIC SHOCK SECONDARY TO SEVERE SYSTOLIC AND DIASTOLIC BIVENTRICULAR FAILURE

Salman Allana - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

Methylprednisolone

ST SEGMENT ELEVATION MYOCARDIAL INFARCTION SECONDARY TO KOUNIS SYNDROME RESULTING FROM BEE STINGS

Evan L. Hardegree - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Epinephrine

Filters

3340 Abstracts